Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 30, 2013
The CCND1 G870A polymorphism and susceptibility to bladder cancerJing Li, Fei Luo, Hongtuan Zhang, et al.
Frontiers in Cell and Developmental Biology|August 16, 2021
CircGNG4 Promotes the Progression of Prostate Cancer by Sponging miR-223 to Enhance EYA3/c-myc ExpressionShengxian Xu, Zhenpeng Lian, Siyang Zhang, et al.
Investigative Ophthalmology & Visual Science|May 8, 2012
Association of TP53 polymorphisms with primary open-angle glaucoma: a meta-analysisYatu Guo, Hongtuan Zhang, Xia Chen, et al.
Urologia Internationalis|December 22, 2012
Lack of association between COMT Val158Met polymorphism and prostate cancer susceptibilityHongtuan Zhang, Zhihong Zhang, Jingsheng Wu, et al.
World Journal of Surgical Oncology|August 15, 2020
Impact of positive surgical margin location and perineural invasion on biochemical recurrence in patients undergoing radical prostatectomyZhenpeng Lian, Hongtuan Zhang, Zhaowei He, et al.
International Urogynecology Journal|November 12, 2025
Prevalence and Trends in Overactive Bladder Among Women in the United States, 2005-2020Hongbo Xie, Yunan Liang, Xin Zhao, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 3, 2016
miR-539 inhibits prostate cancer progression by directly targeting SPAG5Hongtuan Zhang, Shadan Li, Xiong Yang, et al.
World Journal of Surgical Oncology|October 15, 2025
Robot-assisted laparoscopic prostate-sparing resection of an extremely rare periprostatic solitary fibrous tumor: a case report and literature reviewHongbo Xie, Yunan Liang, Xin Zhao, et al.
International Journal of Molecular Sciences|July 3, 2014
Protein tyrosine kinase 7 (PTK7) as a predictor of lymph node metastases and a novel prognostic biomarker in patients with prostate cancerHongtuan Zhang, Andi Wang, Shiyong Qi, et al.
Cancer Biomarkers : Section a of Disease Markers|August 1, 2022
MiR-96-5p induced NDRG1 deficiency promotes prostate cancer migration and invasion through regulating the NF-κB signaling pathwayZhenpeng Lian, Taihao Chang, Shenfei Ma, et al.
Pageof 4